Patents-Review.com
🔗 Permalink
Assignee profile:

NYKODE THERAPEUTICS ASA

City:

Oslo

Country:

Norway

Published Applications:

19

Last publication date:

2026-06-11

Patent Grants:

7

Last grant date:

2025-07-15

Top Inventors for applications by NYKODE THERAPEUTICS ASA

These are the the leading inventors for applications assigned to NYKODE THERAPEUTICS ASA:

Recent patent applications by NYKODE THERAPEUTICS ASA

NYKODE THERAPEUTICS ASA based in Oslo, NO has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2026-06-11
US20260162767A1
Physics

METHOD FOR SELECTING NEOTOPES

 #2 | 2025-11-06
US20250339509A1
Human necessities

IMMUNOGENIC CONSTRUCTS AND VACCINES FOR USE IN THE PROPHYLACTIC AND THERAPEUTIC TREATMENT OF INFECTIOUS DISEASES

 #3 | 2025-09-18
US20250288654A1
Human necessities

TOLERANCE-INDUCING CONSTRUCTS AND COMPOSITIONS AND THEIR USE FOR THE TREATMENT OF IMMUNE DISORDERS

 #4 | 2025-07-10
US20250222085A1
Human necessities

CO-EXPRESSION OF CONSTRUCTS AND IMMUNOSTIMULATORY COMPOUNDS

 #5 | 2025-06-19
US20250195632A1
Human necessities

TOLERANCE-INDUCING CONSTRUCTS AND COMPOSITION AND THEIR USE FOR THE TREATMENT OF IMMUNE DISORDERS

 #6 | 2025-02-13
US20250049910A1
Human necessities

Immunogenic Constructs And Vaccines For Use In The Prophylactic And Therapeutic Treatment Of Diseases Caused By SARS-CoV-2

 #7 | 2024-08-01
US20240252625A1
Human necessities

CO-EXPRESSION OF CONSTRUCTS AND IMMUNOINHIBITORY COMPOUNDS

 #8 | 2024-05-30
US20240173391A1
Human necessities

THERAPEUTIC COMBINATION FOR TREATING CANCER

 #9 | 2024-04-25 ✅ Patent 12,358,989 granted on 2025-07-15
US20240132596A1
Chemistry; metallurgy

HLA BINDING VACCINE MOIETIES AND USES THEREOF

 #10 | 2023-09-28
US20230303718A1
Chemistry; metallurgy

Modified Antibody

 #11 | 2023-09-21
US20230293650A1
Human necessities

INDIVIDUALIZED THERAPEUTIC ANTICANCER VACCINE

 #12 | 2023-06-01
US20230165952A1
Human necessities

BETACORONAVIRUS PROPHYLAXIS AND THERAPY

 #13 | 2023-03-02 ✅ Patent 12,516,116 granted on 2026-01-06
US20230065226A1
Chemistry; metallurgy

HOMODIMERIC PROTEIN CONSTRUCTS

 #14 | 2023-02-16
US20230048561A1
Chemistry; metallurgy

Modified Antibody

 #15 | 2022-11-24 ✅ Patent 12,059,459 granted on 2024-08-13
US20220370579A1
Human necessities

Therapeutic anticancer neoepitope vaccine

 #16 | 2022-07-07 ✅ Patent 12,144,858 granted on 2024-11-19
US20220211843A1
Human necessities

Immune-stimulatory compositions and use thereof

 #17 | 2021-12-30 ✅ Patent 11,780,924 granted on 2023-10-10
US20210403572A1
Chemistry; metallurgy

HLA binding vaccine moieties and uses thereof

 #18 | 2021-12-16 ✅ Patent 12,462,898 granted on 2025-11-04
US20210388438A1
Chemistry; metallurgy

METHOD FOR SELECTING NEOEPITOPES

 #19 | 2020-07-30 ✅ Patent 11,479,605 granted on 2022-10-25
US20200239568A1
Chemistry; metallurgy

Homodimeric protein constructs

Also check out Nykode Therapeutics ASA's (Oslo, Norway) applicant profile with 17 patent applications submitted.

AssigneeID:

330848 ⎘